.svg "CTA Arrow")
.png)
News & Insights from IRC Partners
IRC Partners publishes institutional-grade research on capital stack structuring, GP/LP economics, debt and equity positioning, fund formation, and LP due diligence for real estate sponsors and growth-stage founders.
Each article is written to the standard institutional investors use to evaluate sponsors, not as general education.
September 24, 2026
What Sales Efficiency Metrics Matter Most to Growth Equity Firms at Series B?
Understand the Magic Number, CAC payback, and LTV:CAC metrics growth equity firms use to evaluate Series B SaaS efficiency.
September 24, 2026
How Do Growth Equity Investors Calculate CAC Payback for a Series B SaaS Company?
Calculate fully loaded CAC payback by ACV tier, gross margin, and trend line to support a stronger Series B narrative.
September 24, 2026
What Does an Institutional Growth Equity Investor Expect In a Go-To-Market Efficiency Analysis?
Learn the five GTM efficiency inputs growth equity investors test before deciding whether a Series B revenue motion can scale.
September 23, 2026
What are the Biggest Red Flags in a Series B SaaS Customer Cohort Analysis?
Five customer cohort red flags Series B SaaS investors examine before diligence, plus the corrective steps founders can take.
September 23, 2026
How Should a Series B Company Present Customer Churn by Cohort, Segment, and Contract Size?
Show investors how retention varies by cohort, ICP, and ACV tier before blended churn becomes a Series B diligence concern.
September 22, 2026
What Do Series B Growth Equity Investors Look for in a Company?
Series B investors assess revenue quality, retention, efficiency, margins, sales repeatability, team readiness, capital structure, and market size.
September 22, 2026
How Do Growth Equity Investors Assess Product-Market Fit After a Company Reaches $10 Million ARR?
How growth equity investors assess product-market fit at $10M ARR through retention, expansion, ICP focus, and sales efficiency metrics.
September 22, 2026
What Revenue-Quality Issues Can Cause Growth Equity Investors To Pass On a Series B Deal?
Four revenue-quality issues that can stall a Series B raise, including customer concentration, ARR contamination, margins, and ACV decline.
September 21, 2026
Why Did Investors Reject My Investment Committee Presentation?
Why IC presentations fail and how sponsors can diagnose mandate, credibility, and structural issues before the next investor meeting.
Schedule A Meeting
You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.
We onboard a maximum of seven
new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.
